Filosi, M.; Mueller-Myhsok, B.; Muglia, P.; Domenici, E.: Blood-based autism spectrum disorder signatures from the Italian autism network collection. In European Neuropsychopharmacology, 29, p. S912 - S912. 25th World Congress of Psychiatric Genetics (WCPG), Orlando, FL, October 13, 2017 - October 17, 2017. Elsevier, Amsterdam (2019)

Forstner, A. J.; Awasthi, S.; Wolf, C.; Maron, E.; Erhardt, A.; Eriksson, E.; Lavebratt, C.; Allgulander, C.; Woldbye, D. P. D.; Mors, O. et al.; Binder, E. B.; Ruck, C.; Ripke, S.; Deckert, J.; Schumacher, J.: Genome-wide association study of panic disorder. In European Neuropsychopharmacology, 29, p. S776 - S776. 25th World Congress of Psychiatric Genetics (WCPG), Orlando, FL, October 13, 2017 - October 17, 2017. Elsevier, Amsterdam (2019)

Kalman, J.; Papiol, S.; Heilbronner, U.; Andlauer, T. F. M.; Anderson-Schmidt, H.; Budde, M.; Gade, K.; Herms, S.; Forstner, A. J.; Frank, J. et al.; Degenhardt, F.; Noethen, M.; Rietschel, M.; Falkai, P.; Schulze, T.: Effects of schizophrenia and bipolar polygenic risk scores on age at onset in bipolar disorder. In European Neuropsychopharmacology, 29, p. S967 - S967. 25th World Congress of Psychiatric Genetics (WCPG), Orlando, FL, October 13, 2017 - October 17, 2017. Elsevier, Amsterdam (2019)

Raikkonen, K.; Suarez, A.; Lahti, J.; Czamara, D.; Lahti, M.; Knight, A.; Girchenko, P.; Hamalainen, E.; Kajantie, E.; Laivuori, H. et al.; Villa, P.; Reynolds, R.; Smith, A.; Binder, E.: The Epigenetic Clock At Birth: Associations With Maternal Antenatal Depression And Child Psychiatric Problems. In European Neuropsychopharmacology, 29, p. S748 - S748. 25th World Congress of Psychiatric Genetics (WCPG), Orlando, FL, October 13, 2017 - October 17, 2017. Elsevier, Amsterdam (2019)

Mehta, D.; Rex-Haffner, M.; Sondergaard, H. B.; Pinborg, A.; Binder, E.; Frokjaer, V. G.: Biological changes in a pharmacologically-induced depression model confirm the role of estrogen sensitivity in perinatal depression. In European Neuropsychopharmacology, 29, pp. S45 - S46. 31st Congress of the European-College-of-Neuropsychopharmacology (ECNP), Barcelona, SPAIN, October 06, 2018 - October 09, 2018. Elsevier, Amsterdam (2019)

Weeger, J.; Schmidt, U.; Uhr, M.; Steiger, A.: Cortisol response to nocturnal psychosocial stress in dependence of CRHR1 genotype. In European Neuropsychopharmacology, 29, pp. S525 - S526. 31st Congress of the European-College-of-Neuropsychopharmacology (ECNP), Barcelona, SPAIN, October 06, 2018 - October 09, 2018. Elsevier, Amsterdam (2019)

Leerssen, J.; Blanken, T. F.; Pozzi, E.; Jahanshad, N.; Aftanas, L.; Baune, B. T.; Dannlowski, U.; Frodl, T.; Godlewska, B. R.; Gotlib, I. H. et al.; Grotegerd, D.; Gruber, O.; Hatton, S. N.; Hickie, I. B.; Irungu, B.; Jaworska, N.; Kircher, T.; Krug, A.; Lagopoulos, J.; Li, M.; MacMaster, F. P.; McIntosh, A. M.; Osipov, E.; Portella, M. J.; Sacchet, M. D.; Saemann, P. G.; Simulionyte, E.; Soares, J. C.; Walter, M.; Whalley, H.; Veltman, D.; Thompson, P. M.; Schmaal, L.; Van Someren, E. J. W.: Brain structural correlates of insomnia severity in major depressive disorder: Results from the ENIGMA-MDD consortium. In European Neuropsychopharmacology, 29, pp. S688 - S690. ECNP Workshop on Early Career Scientists in Europe, Nice, FRANCE, March 07, 2019 - March 10, 2019. Elsevier, Amsterdam (2019)

Martinelli, S.; Wiechmann, T.; Kathrin, H.; Meinhold, L.; Roeh, S.; Sauer, S.; Gassen, N.; Binder, E. B.: Unravelling the differential role of FKBP51 (FK506 Binding Protein 5) isoforms in different cellular pathways. In European Neuropsychopharmacology, 29, pp. S652 - S653. ECNP Workshop on Early Career Scientists in Europe, Nice, FRANCE, March 07, 2019 - March 10, 2019. Elsevier, Amsterdam (2019)

Schaefers, C.; Strobelt, R.; Seeger, T.; Thiermann, H.; Rein, T.; Schmidt, A.: Development of a neuronal test model from induced pluripotent stem cells to study the effects of exposure to various warfare agents. In Naunyn-Schmiedebergs Archives of Pharmacology, 392, p. S63 - S63. 21st Annual Meeting of the German-Society-for-Experimental-and-Clinical-Pharmacology-and-Toxicology (DGPT) / 21st Annual Meeting of the Association-of-the-Clinical-Pharmacology-Germany (VKliPha), Stuttgart, GERMANY, February 25, 2019 - February 28, 2019. Springer-Verlag Heidelberg, Heidelberg (2019)

Andlauer, T.; Muhleisen, T.; Hoffstaedter, F.; Teumer, A.; Teuber, A.; Reinbold, C.; Herms, S.; Teismann, H.; Moebus, S.; Grabe, H. J. et al.; Noethen, M.; Amunts, K.; Eickhoff, S.; Mueller-Myhsok, B.; Cichon, S.: GENETIC FACTORS INFLUENCING THE COMMON NEUROBIOLOGICAL SUBSTRATE FOR MENTAL DISORDERS. In EUROPEAN NEUROPSYCHOPHARMACOLOGY, 29, p. S798 - S798. 25th World Congress of Psychiatric Genetics (WCPG), Orlando, FL, October 13, 2017 - October 17, 2017. (2019)

Arloth, J.; Eraslan, G.; Andlauer, T.; Gieger, C.; Gold, R.; Heilmann-Heimbach, S.; Kacprowski, T.; Meitinger, T.; Laudes, M.; Luessi, F. et al.; Mueller-Myhsok, B.; Nischwitz, S.; Peters, A.; Paul, F.; Rawal, R.; Strauch, K.; Wiendl, H.; Hemmer, B.; Theis, F.; Binder, E.; Mueller, N.: Identification of functionally relevant genetic variants associated with multiple sclerosis using deep learning. In MULTIPLE SCLEROSIS JOURNAL, 25, pp. 906 - 907. 35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, Stockholm, SWEDEN, September 11, 2019 - September 13, 2019. (2019)

Athreya, A. P.; Neavin, D.; Carrillo-Roa, T.; Frye, M. A.; Skime, M.; Rush, A.; Bobo, W. V.; Wang, L.; Binder, E.; Iyer, R. K. et al.; Weinshilboum, R. M.: ARTIFICIAL-INTELLIGENCE-AUGMENTED PSYCHIATRY WITH PHARMACOGENOMICS: TOWARDS INDIVIDUALIZATION OF ANTIDEPRESSANT SELECTION IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER. In CLINICAL PHARMACOLOGY & THERAPEUTICS, 105, pp. S80 - S81. (2019)

Awaloff, Y.; Provencal, N.; Carrillo Roa, T.; Halldorsdottir, T.; Boadie, D.; Mayberg, H.; Craighed, E.; Czamara, D.; Binder, E.: INTERACTIONS BETWEEN GENOTYPE AND ENVIRONMENT HAVE A STRONG EFFECT ON VARIABILITY IN DNA METHYLATION IN PSYCHIATRIC PATIENTS. In EUROPEAN NEUROPSYCHOPHARMACOLOGY, 29, p. S984 - S984. 25th World Congress of Psychiatric Genetics (WCPG), Orlando, FL, October 13, 2017 - October 17, 2017. (2019)

Binder, E.; Burmeister, M.: MECHANISMS OF EARLY ADVERSITY ASSOCIATED INCREASES IN RISK FOR PSYCHIATRIC DISORDERS. In EUROPEAN NEUROPSYCHOPHARMACOLOGY, 29, pp. S746 - S747. 25th World Congress of Psychiatric Genetics (WCPG), Orlando, FL, October 13, 2017 - October 17, 2017. (2019)

Breen, M.; Tylee, D.; Maihofer, A.; Tsuang, M.; Chandler, S.; Mehta, D.; Binder, E.; Hess, J.; Baker, D.; Risbrough, V. et al.; Nievergelt, C.; Buxbaum, J.; Glatt, S.: PTSD BLOOD TRANSCRIPTOME MEGA-ANALYSIS: INFLAMMATORY PATHWAYS ACROSS BIOLOGICAL SEX AND MODES OF TRAUMA. In EUROPEAN NEUROPSYCHOPHARMACOLOGY, 29, pp. 1056 - 1057. 26th World Congress of Psychiatric Genetics (WCPG), Glasgow, SCOTLAND, October 11, 2018 - October 15, 2018. (2019)

Budde, M.; Gade, K.; Anderson-Schmidt, H.; Kalman, J.; Senner, F.; Adorjan, K.; Schulte, E. C.; Comes, A. L.; Papiol, S.; Andlauer, T. F. M. et al.; Rietschel, M.; Noethen, M. M.; Falkai, P.; Schulze, T. G.; Heilbronner, U.: PSYCOURSE: A TRANSDIAGNOSTIC STUDY ON THE COURSE OF SEVERE MENTAL DISORDERS. In EUROPEAN NEUROPSYCHOPHARMACOLOGY, 29, p. 1236 - 1236. 26th World Congress of Psychiatric Genetics (WCPG), Glasgow, SCOTLAND, October 11, 2018 - October 15, 2018. (2019)

Comes, A.; Adorjan, K.; Andlauer, T.; Budde, M.; Degenhardt, F.; Forstner, A. J.; Gade, K.; Heilbronner, U.; Kalman, J.; Kondofersky, I. et al.; Papiol, S.; Senner, F.; Sivalingam, S.; Falkai, P.; Schulze, T.: THE ROLE OF ENVIRONMENTAL STRESS AND DNA METHYLATION IN THE LONGITUDINAL COURSE OF BIPOLAR DISORDER. In EUROPEAN NEUROPSYCHOPHARMACOLOGY, 29, pp. 1300 - 1301. 26th World Congress of Psychiatric Genetics (WCPG), Glasgow, SCOTLAND, October 11, 2018 - October 15, 2018. (2019)

Czamara, D.; Eraslan, G.; Lahti, J.; Figueiredo, A. S.; Girchenko, P.; Lahti-Pulkkinen, M.; Hamalainen, E.; Kajantie, E.; Laivuori, H.; Villa, P. et al.; Reynolds, R.; Mueller, N.; Theis, F. J.; Raikkonen, K.; Binder, E.: GENOTYPE, PRENATAL ENVIRONMENT OR BOTH-WHAT SHAPES THE NEWBORN'S EPIGENOME? In EUROPEAN NEUROPSYCHOPHARMACOLOGY, 29, p. 1037 - 1037. 26th World Congress of Psychiatric Genetics (WCPG), Glasgow, SCOTLAND, October 11, 2018 - October 15, 2018. (2019)

Czamara, D.; Eraslan, G.; Suarez, A.; Girchenko, P.; Lahti, J.; Lahti, M.; Hamalainen, E.; Kajantie, E.; Laivuori, H.; Reynolds, R. M. et al.; Kondofersky, I.; Mueller, N. S.; Theis, F. J.; Raikkonen, K.; Binder, E. B.: WHAT SHAPES THE CHILD'S EPIGENOME: GENOTYPE, PRENATAL ENVIRONMENT OR BOTH? In EUROPEAN NEUROPSYCHOPHARMACOLOGY, 29, p. S985 - S985. 25th World Congress of Psychiatric Genetics (WCPG), Orlando, FL, October 13, 2017 - October 17, 2017. (2019)

Dammering, F.; Martins, J.; Hoffmann, F.; Provencal, N.; de Punder, K.; Overfeld, J.; Czamara, D.; Rex-Haffner, M.; McEwen, L.; Kobor, M. et al.; Winter, S.; Buss, C.; Entringer, S.; Binder, E.; Heim, C.: Psychiatric symptom severity mediates the effect of adversity on epigenetic aging in children aged 3-5 years. In PSYCHONEUROENDOCRINOLOGY, 107, p. 30 - 30. 49th Annual Conference of the International-Society-of-Psychoneuroendocrinology - 50 Years of Psychoneuroendocrinology - Returning to Where It All Began, Milan, ITALY, August 29, 2019 - August 31, 2019. (2019)